1.Clinical Efficacy of Self-Prescribed Chaigui Tongmai Formula Combined with Warm Needle Moxibustion in Treating Lower Extremity Arteriosclerosis Obliterans with Cold Coagulation and Blood Stasis Syndrome
Lei YAN ; Hongqing XING ; Kaiming QIAO
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(11):2736-2742
Objective To observe the clinical efficacy of self-prescribed Chaigui Tongmai Formula combined with warm needle moxibustion in treating lower extremity arteriosclerosis obliterans(LEASO)with cold coagulation and blood stasis syndrome.Methods A total of 90 patients diagnosed with LEASO of cold coagulation and blood stasis syndrome who were treated in the outpatient and inpatient departments of the Ulcer and Vascular Disease Department of Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine between November 2022 and November 2023 were selected as study subjects.Patients were randomly divided into an observation group and a control group using a random number table,with 45 cases in each group.Both groups received health education and conventional treatment.The control group was treated with oral administration of self-prescribed Chaigui Tongmai Formula,while the observation group received additional warm needle moxibustion based on the control group's treatment.Both groups were treated for 3 weeks.After treatment,clinical efficacy was evaluated by observing changes in TCM syndrome scores,intermittent claudication distance,ankle-brachial index(ABI),toe-brachial index(TBI),hemodynamic parameters,and serum inflammatory factor levels before and after treatment in both groups.Safety and adverse reactions were also assessed.Results(1)The total effective rate was 95.56%(43/45)in the observation group and 80.00%(36/45)in the control group.The efficacy of the observation group was significantly superior to that of the control group,with a statistically significant difference(P<0.05).(2)After treatment,TCM syndrome scores and intermittent claudication distance were significantly improved in both groups(P<0.05),and the improvement in the observation group was significantly greater than that in the control group,with a statistically significant difference(P<0.05).(3)After treatment,intermittent claudication distance was significantly improved in both groups(P<0.05),and the improvement in the observation group was significantly greater than that in the control group,with a statistically significant difference(P<0.05).(4)After treatment,ABI and TBI were significantly improved in both groups(P<0.05),and the improvement in the observation group was significantly greater than that in the control group,with a statistically significant difference(P<0.05).(5)After treatment,whole blood low-shear viscosity,high-shear viscosity,and plasma viscosity levels were significantly improved in both groups(P<0.05),and the improvement in the observation group was significantly greater than that in the control group,with a statistically significant difference(P<0.05).(6)After treatment,levels of IL-18,hs-CRP,and IC AM-1 were significantly improved in both groups(P<0.05),and the improvement in the observation group was significantly greater than that in the control group,with a statistically significant difference(P<0.05).(7)During treatment,the incidence of adverse reactions was 4.44%(2/45)in the observation group and 6.66%(3/45)in the control group.There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Self-prescribed Chaigui Tongmai Formula combined with warm needle moxibustion significantly promotes the recovery of clinical symptoms,reduces inflammatory responses,improves hemodynamic parameters,and enhances the quality of life in patients with LEASO of cold coagulation and blood stasis syndrome,demonstrating notable efficacy and good safety.
2.Parapapillary atrophy, choroidal vascularity index and their correlation in different degrees of myopia
Minhui WU ; Yilin QIAO ; Yufeng YE ; Weiqian GAO ; Kaiming RUAN ; Dan CHENG ; Meixiao SHEN ; Shuangqing WU ; Xueying ZHU ; Xinxin YU ; Zuhui ZHANG ; Lijun SHEN
Chinese Journal of Ocular Fundus Diseases 2022;38(10):829-834
Objective:To observe the peripapillary atrophy (PPA) and peripapillary choroidal vascularity index (CVI) in patients with different degrees of myopia and to analyze their correlations.Methods:A cross-sectional clinical study. From September 2021 to December 2021, 281 mypoic patients of 281 eyes treated in Eye Hospital of Wenzhou Medical University at Hangzhou were included in this study, and the right eye was used as the treated eye. There were 135 eyes in 135 males and 146 eyes in 146 females. The age was 28.18±5.78 years. The spherical equivalent refraction (SE) was -5.13±2.33 D. The patients were divided into three groups: low myopia group (group A, -3.00 D
3.Reiview of metabolic syndrome in TCM clinical and experimental studies
Shuquan LYU ; Shufang ZHANG ; Zhenqiang WANG ; Kaiming QIAO ; Xiuhai SU ; Lina XIE ; Fengzhe SU ; Qinghai WANG
International Journal of Traditional Chinese Medicine 2017;39(3):277-280
The paper summarized the literature in recent 5 years about the researches on the metabolic syndrome (MS) in traditional Chinese medicine. The paper discussed the etiology and pathogenesis, summarized the clinical research and experiment of traditional Chinese medicine for MS.

Result Analysis
Print
Save
E-mail